KR940006583A - 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 - Google Patents
약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 Download PDFInfo
- Publication number
- KR940006583A KR940006583A KR1019930018067A KR930018067A KR940006583A KR 940006583 A KR940006583 A KR 940006583A KR 1019930018067 A KR1019930018067 A KR 1019930018067A KR 930018067 A KR930018067 A KR 930018067A KR 940006583 A KR940006583 A KR 940006583A
- Authority
- KR
- South Korea
- Prior art keywords
- adsorbents
- adsorbate
- nonsolid
- manufacture
- pharmaceutical compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP4230371.0 | 1992-09-11 | ||
| DE4230371 | 1992-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR940006583A true KR940006583A (ko) | 1994-04-25 |
Family
ID=6467712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019930018067A Withdrawn KR940006583A (ko) | 1992-09-11 | 1993-09-09 | 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0587137A1 (enExample) |
| JP (1) | JPH06192093A (enExample) |
| KR (1) | KR940006583A (enExample) |
| AU (1) | AU663000B2 (enExample) |
| CA (1) | CA2105913A1 (enExample) |
| FI (1) | FI933954L (enExample) |
| HU (1) | HUT67577A (enExample) |
| IL (1) | IL106953A0 (enExample) |
| MX (1) | MX9305578A (enExample) |
| NO (1) | NO933237L (enExample) |
| NZ (1) | NZ248627A (enExample) |
| TW (1) | TW222585B (enExample) |
| ZA (1) | ZA936695B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1166801A1 (en) * | 1993-06-04 | 2002-01-02 | Warner-Lambert Company | Preparations containing silicon dioxide to improve the taste thereof |
| US5626878A (en) * | 1995-01-10 | 1997-05-06 | Warner Lambert Company | Reduction of electrostatic forces between magnesium trisilicate adsorbates |
| CZ20012201A3 (cs) * | 1998-12-18 | 2001-09-12 | Abbott Laboratories | Přípravek s řízeným uvolňováním obsahující divalproex sodný |
| CN101001613B (zh) * | 2004-06-28 | 2010-09-29 | 生命周期药物公司 | 作为液体制剂载体的多孔片剂 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2879161A (en) * | 1956-05-14 | 1959-03-24 | American Cyanamid Co | Stable dry powder compositions containing choline chloride and methods of preparing same |
| DE3409063A1 (de) * | 1984-03-13 | 1985-09-19 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von fliessfaehigen cholinchlorid-kieselsaeure-pulvern |
| DE3924093A1 (de) * | 1989-07-20 | 1991-02-07 | Hoechst Ag | N,n'-bis(alkoxy-alkyl)-pyridin-2,4-dicarbonsaeurediamide, verfahren zu deren herstellung sowie deren verwendung |
| DE4020570A1 (de) * | 1990-06-28 | 1992-01-02 | Hoechst Ag | 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung |
| GB9025251D0 (en) * | 1990-11-20 | 1991-01-02 | Solomon Montague C | Nifedipine dosage forms |
-
1993
- 1993-03-02 TW TW082101487A patent/TW222585B/zh active
- 1993-09-08 EP EP93114413A patent/EP0587137A1/de not_active Withdrawn
- 1993-09-09 NZ NZ248627A patent/NZ248627A/xx unknown
- 1993-09-09 KR KR1019930018067A patent/KR940006583A/ko not_active Withdrawn
- 1993-09-09 IL IL106953A patent/IL106953A0/xx unknown
- 1993-09-09 FI FI933954A patent/FI933954L/fi not_active Application Discontinuation
- 1993-09-09 HU HU9302555A patent/HUT67577A/hu unknown
- 1993-09-10 ZA ZA936695A patent/ZA936695B/xx unknown
- 1993-09-10 JP JP5225707A patent/JPH06192093A/ja active Pending
- 1993-09-10 MX MX9305578A patent/MX9305578A/es not_active Application Discontinuation
- 1993-09-10 NO NO933237A patent/NO933237L/no unknown
- 1993-09-10 AU AU46262/93A patent/AU663000B2/en not_active Ceased
- 1993-09-10 CA CA002105913A patent/CA2105913A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO933237D0 (no) | 1993-09-10 |
| IL106953A0 (en) | 1993-12-28 |
| JPH06192093A (ja) | 1994-07-12 |
| TW222585B (enExample) | 1994-04-21 |
| MX9305578A (es) | 1994-03-31 |
| NO933237L (no) | 1994-03-14 |
| AU4626293A (en) | 1994-03-17 |
| FI933954A7 (fi) | 1994-03-12 |
| HU9302555D0 (en) | 1993-11-29 |
| CA2105913A1 (en) | 1994-03-12 |
| FI933954L (fi) | 1994-03-12 |
| EP0587137A1 (de) | 1994-03-16 |
| NZ248627A (en) | 1995-01-27 |
| HUT67577A (en) | 1995-04-28 |
| FI933954A0 (fi) | 1993-09-09 |
| ZA936695B (en) | 1994-04-05 |
| AU663000B2 (en) | 1995-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04995B1 (et) | Fenofibraati sisaldav farmatseutiline kompositsioon ja meetod selle valmistamiseks | |
| AU3567295A (en) | Pharmaceutical preparation containing metformin and a process for producing it | |
| CA2134964A1 (en) | Bridged Aza-Bicyclic Derivatives as Substance P Antagonists | |
| BR0208126A (pt) | Conjugados de ingrediente ativo de has | |
| IL114210A0 (en) | Production of solid microspheres containing agriculturally active compounds | |
| MY129613A (en) | Cannabinoid receptor binding compounds | |
| CA2040889A1 (en) | Nematicidal compositions comprising nitro-or halo-benzisothiazoles | |
| CA2290622A1 (en) | Selective thyroid hormone analogs | |
| CA2014008A1 (en) | Benzimidazoles, medicaments containing these compounds and processes for their preparation | |
| EP0326357A3 (en) | Avermectin derivatives | |
| CA2390649A1 (en) | 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them | |
| FI940696A0 (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
| WO2002050067A3 (en) | Pharmaceutical heterocyclic compounds | |
| KR940006583A (ko) | 약제학적 조성물 제조용 보조 혼합물 및 비고체 활성 화합물의 피흡착질 | |
| CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
| JPS643040A (en) | Chemical admixture for cement | |
| PT1282617E (pt) | Derivados de hidantoína com afinidade para os receptores da somatostatina | |
| MEP88408A (en) | Pharmaceutical compositions containing oligosaccharides and preparation thereof | |
| WO2002060405A8 (en) | Veterinary dermatologic composition comprising a sphingoid base and/or a sphingoid base derivative | |
| CA2360894A1 (en) | (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same | |
| WO1999048851A3 (en) | Processes for preparing intermediates | |
| CA2326716A1 (en) | Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma | |
| DE69222143D1 (de) | Indanderivate | |
| KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
| CA2355720A1 (en) | New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19930909 |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |